GMGilles Mentha

Gilles Mentha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gilles Mentha has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence

    by Lorenzo A. Orci, Stéphanie Lacotte, Graziano Oldani, Philippe Morel, Gilles Mentha, Christian Toso

    Hepatic ischemia/reperfusion (I/R) injury is a common clinical challenge. Despite accumulating evidence regarding its mechanisms and potential therapeutic approaches, hepatic I/R is still a leading cause of organ dysfunction, morbidity, and resource utilization, especially in those patients with underlying parenchymal abnormalities. In the oncological setting, there are growing concerns regarding the deleterious impact of I/R injury on the risk of post-surgical tumor recurrence. This review aims at giving the last updates regarding the role of hepatic I/R and liver parenchymal quality injury in the setting of oncological liver surgery, using a “bench-to-bedside” approach. Relevant medical literature was identified by searching PubMed and hand scanning of the reference lists of articles considered for inclusion. Numerous preclinical models have depicted the impact of I/R injury and hepatic parenchymal quality (steatosis, age) on increased cancer growth in the injured liver. Putative pathophysiological mechanisms linking I/R injury and liver cancer recurrence include an increased implantation of circulating cancer cells in the ischemic liver and the upregulation of proliferation and angiogenic factors following the ischemic insult. Although limited, there is growing clinical evidence that I/R injury and liver quality are associated with the risk of post-surgical cancer recurrence. In conclusion, on top of its harmful early impact on organ function, I/R injury is linked to increased tumor growth. Therapeutic strategies tackling I/R injury could not only improve post-surgical organ function, but also allow a reduction in the risk of cancer recurrence.


  • Open Access

    Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer

    by Surennaidoo P Naiken, Christian Toso, Laura Rubbia-Brandt, Theodoros Thomopoulos, Arnaud Roth, Gilles Mentha, Philippe Morel, Pascal Gervaz

    Complete pathological response occurs in 10–20% of patients with rectal cancer who are treated with neoadjuvant chemoradiation therapy prior to pelvic surgery. The possibility that complete pathological response of rectal cancer can also occur with neoadjuvant chemotherapy alone (without radiation) is an intriguing hypothesis. A 66-year old man presented an adenocarcinoma of the rectum with nine liver metastases (T3N1M1). He was included in a reverse treatment, aiming at first downsizing the liver metastases by chemotherapy, and subsequently performing the liver surgery prior to the rectum resection. The neoadjuvant chemotherapy consisted in a combination of oxaliplatin, 5-FU, irinotecan, leucovorin and bevacizumab (OCFL-B). After a right portal embolization, an extended right liver lobectomy was performed. On the final histopathological analysis, all lesions were fibrotic, devoid of any viable cancer cells. One month after liver surgery, the rectoscopic examination showed a near-total response of the primary rectal adenocarcinoma, which convinced the colorectal surgeon to perform the low anterior resection without preoperative radiation therapy. Macroscopically, a fibrous scar was observed at the level of the previously documented tumour, and the histological examination of the surgical specimen did not reveal any malignant cells in the rectal wall as well as in the mesorectum. All 15 resected lymph nodes were free of tumour, and the final tumour stage was ypT0N0M0. Clinical outcome was excellent, and the patient is currently alive 5 years after the first surgery without evidence of recurrence. The presented patient with stage IV rectal cancer and liver metastases was in a unique situation linked to its inclusion in a reversed treatment and the use of neoadjuvant chemotherapy alone. The observed achievement of a complete pathological response after chemotherapy should promote the design of prospective randomized studies to evaluate the benefits of chemotherapy alone in patients with stages II-III rectal adenocarcinoma (without metastasis).


  • Operative Management of Colorectal Liver Metastases

    by Sylvain Terraz, Axel Andres, Christian Toso, Laura Rubbia-Brandt, Pietro Majno, Gilles Mentha

    In this review, the authors describe the management of patients with colorectal liver metastases in the era of effective chemotherapies and advanced interventional radiology. They give special attention to the surgical procedures that decrease the operative mortality and morbidity and produce clear margins. They discuss the best timing for chemotherapy, resection of the primary tumor, and resection of the liver metastases in an effort to improve long-term survival. The use of preoperative portal vein embolization, two-stage hepatectomy for bilobar synchronous liver metastases, and the liver-first strategy have allowed for treatment of patients with advanced disease with a curative intent, and to obtain 5-year overall survival of 30 to 60% despite poor prognostic factors and a cure (no recurrence at 10 years) in more than 20% of patients. These rates would have been unimaginable only two decades ago.


  • Patterns of recurrence after resection of intrahepatic cholangiocarcinoma: Results from a multi-institutional cohort of 449 patients.

    by Ioannis Hatzaras, Michael A. Choti, Richard D. Schulick, Sorin Alexandrescu, Carlo Pulitano, Bryan M. Clary, Andrew X. Zhu, Irinel Popescu, Hugo Marques, Eduardo Barroso, et al.

    267 Background: Outcomes following surgical management of intrahepatic cholangiocarcionma (ICC) have largely focused on overall survival. Data on recurrence following surgery for ICC are limited. We sought to investigate rates and patterns of recurrence in patients following curative intent surgery for ICC. Methods: 449 patients who underwent surgery for ICC between 1973 and 2010 were identified from an international multi-institutional database. Clinicopathologic data, recurrence patterns, and recurrence-free survival (RFS) were analyzed. Results: Most patients had a solitary tumor (70%) with a median tumor size of 6.5 cm. The majority of lesions did not have vascular invasion (69%). Surgical treatment was < hemi-hepatectomy (47%), hemi-hepatectomy (26%), or extended hepatectomy (27%). On pathology, 23% patients had lymph node metastasis and 18% had a microscopically positive (R1) margin. A subset of patients received adjuvant chemotherapy (32%) or chemoradiation (39%). While 5-year overall survival was 31%, 351 (78%) patients recurred with a median RFS time of 13.2 months. First recurrence site was intra-hepatic only (54%), extra-hepatic only (24%), intra- and extra-hepatic (22%). There was no difference in RFS based on site of recurrence (intra-hepatic: 11.2 months; extra-hepatic 11.6 months; intra- and extra-hepatic: 9.6 months; P=0.16). An R1 surgical margin (HR: 1.56, p=0.02) and neural invasion (HR: 1.55, p=0.02) were associated with overall recurrence, while male gender (HR: 1.70, p=0.011), >50% liver parenchyma resection HR: 1.97, p=0.03), primary tumor size (1.05, p=.02), and poor differentiation (HR: 1.92, p=0.01, were associated with intrahepatic recurrence. Receipt of adjuvant therapy was not associated with risk of recurrence (P>0.05). Conclusions: Over 75% of patients developed recurrence following curative intent surgery for ICC. The pattern of failure was distributed relatively equally with half of patients recurring with liver only disease while half had an extrahepatic metastatic site of recurrence. Future efforts need to be directed toward identifying more effective adjuvant regimens given the high rate of recurrence.


  • Open Access

    A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis

    by Saskia Ditisheim, Emiliano Giostra, Pierre R Burkhard, Nicolas Goossens, Gilles Mentha, Antoine Hadengue, Laurent Spahr

    Background: Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed. Aim: To make a diagnosis of HE, we explored the value of ammonia in capillary blood, an equivalent to arterial blood, measured at bedside following an oral glutamine challenge. Methods: We included 57 patients (age 56 yrs; M/F: 37/20) with cirrhosis (alcoholic = 42; MELD score 13.8 [7-29], esophageal varices = 38) and previous episodes of HE (n = 19), but without neurological deficits at time of examination, and 13 healthy controls (age 54 yrs). After psychometric tests and capillary (ear lobe) blood ammonia measurements, 20 gr of glutamine was administered orally. Tests were repeated at 60 minutes (+ blood ammonia at 30'). Minimal HE was diagnosed if values were > 1.5 SD in at least 2 psychometric tests. Follow-up lasted 12 months. Results: The test was well tolerated (nausea = 1; dizziness = 1). Patients showed higher values of capillary blood ammonia over time as compared to controls (0'-30'-60 minutes: 75, 117, 169 versus 52, 59, 78 umol/L, p < 0.05). At baseline, 25 patients (44%) had minimal HE, while 38 patients (67%) met the criteria for HE at 60 minutes (chi2: p < 0.01). For the diagnosis of minimal HE, using the ROC curve analysis, baseline capillary blood ammonia showed an AUC of 0.541 (CI: 0.38-0.7, p = 0.6), while at 60 minutes the AUC was 0.727 (CI: 0.58-0.87, p < 0.006). During follow-up, 18 patients (31%) developed clinical episodes of HE. At multivariate analysis, the MELD score (1.12 [1.018-1.236]), previous episodes of HE (3.2[1.069-9.58]), but not capillary blood ammonia, were independent predictors of event. Conclusions: In patients with cirrhosis and normal neurological examination, bedside determination of ammonia in capillary blood following oral glutamine load is well tolerated and achieves a better diagnostic performance for minimal HE than basal capillary ammonia levels. However, capillary blood ammonia is a poor predictor of development of clinically overt HE.


  • Analytical Concerns Regarding Complications of Elective Liver Resections in a Center With Low Mortality—Reply

    by Axel Andres, Eric Gerstel, Pietro Majno, Philippe Morel, Christian Toso, Gilles Mentha

  • Open Access

    Complications of Elective Liver Resections in a Center With Low Mortality

    by Axel Andres, Christian Toso, Bogdan Moldovan, Eduardo Schiffer, Laura Rubbia-Brandt, Sylvain Terraz, Claude E. Klopfenstein, Philippe Morel, Pietro Majno, Gilles Mentha

    Hepatic resection, the treatment of choice for most patients with focal liver tumors, has changed markedly during the last 2 decades. Although liver resections have become common, particularly in dedicated units with liver transplant facilities where mortality rates are lower than 2%,1-3 more invasive procedures are being performed on sicker patients with the aid of portal embolization,4-6 precise preoperative computed tomographic volumetry,7,8 improved perioperative management,9,10 and, in patients with colorectal metastases, effective neoadjuvant chemotherapies and innovative multidisciplinary strategies.11-14 Hence, despite decidedly lower mortality rates, liver resections remain complex procedures with important risks of perioperative morbidity and mortality.15


  • Caroli disease, bilateral diffuse cystic renal dysplasia, situs inversus, postaxial polydactyly, and preauricular fistulas: a ciliopathy caused by a homozygous NPHP3 mutation

    by Ana-Maria Calinescu-Tuleasca, Armand Bottani, Anne-Laure Rougemont, Jacques Birraux, Marie-Claire Gubler, Claude Le Coultre, Pietro Majno, Gilles Mentha, Eric Girardin, Dominique Belli, et al.

    We report the rare association of Caroli disease (intrahepatic bile duct ectasia associated with congenital hepatic fibrosis), bilateral cystic renal dysplasia, situs inversus, postaxial polydactyly, and preauricular fistulas in a female child. She presented with end-stage renal disease at the age of 1 month, followed by a rapidly progressing hepatic fibrosis and dilatation of the intrahepatic bile ducts, leading to secondary biliary cirrhosis and portal hypertension. Combined liver–kidney transplantation was performed at the age of 4 years, with excellent outcome. DNA analysis showed a NPHP3 (coding nephrocystin-3) homozygote mutation, confirming that this malformation complex is a ciliopathy. Conclusion: This rare association required an exceptional therapeutic approach: combined simultaneous orthotopic liver and kidney transplantation in a situs inversus recipient. The long-term follow-up was excellent with a very good evolution of the renal and hepatic grafts and normalization of growth and weight. This malformation complex has an autosomal recessive inheritance with a 25% recurrence risk in each pregnancy.


    • 26 January 2011
      • Vol. 7  (279) , 192-3

    [Liver transplantation].

    by G Mentha, P Majno, I Morard, C Toso, B Moldovan, A T Antonino, T Berney, P Morel, L Rubbia-Brandt, S Terraz, et al.